Credit rating agency, CARE has reaffirmed D rating to Themis Medicare’s long term bank facilities worth Rs 13.10 crore. The rating agency has also reaffirmed D rating to the company’s short term bank facilities.
The company has received the said rating reaffirmation due to delay in repayment of term loans and interest servicing on its debt obligations owing to liquidity constraints.
Themis Medicare is engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.
